Checkpoint inhibitor re-challenge after immune-related adverse events
Immunotherapy has revolutionised treatment in many cancers, including renal cell [...]
Surgical delay and survival in patients with T2 kidney tumours
This was a retrospective analysis of 11,848 patients who had [...]
NHS to rollout twice weekly testing of NHS staff
The NHS is to rollout twice weekly testing of NHS [...]
New coronavirus vaccine by the end of the year
Fantastic news this morning as the NHS announced an imminent [...]
Future for VHL kidney cancer is bright
Von Hippel-Lindau (VHL) disease–associated renal cell carcinoma (RCC) has always [...]
Nephritis as a potential predictor of response to immune checkpoint inhibitors in kidney cancer
This study, to be published in Journal for Immunotherapy of [...]
γ-Glutamyltransferase as a biomarker in patients on nivolumab for metastatic kidney cacner
A protein called γ-glutamyltransferase can predict survival in patients with [...]
Cryoablation versus partial nephrectomy for T1 kidney tumours
In this study published in Science Direct, the researchers compared [...]
PDIGREE trial: Ipilimumab plus nivolumab with cabozantinib for untreated advanced kidney cancer
During this video interview from UroToday, Dr Tian Zhang from [...]
COVID-19: Cancer screening programmes return to normal?
Oncologists have learnt many lessons during the first wave of [...]
